The company says preclinical trials demonstrate its signature molecule can help prevent cell damage that can lead to ...

Telomir Pharmaceuticals , Inc. (NASDAQ:TELO), a $141 million market cap biopharmaceutical company engaged in age-reversal science, has announced significant preclinical study results today, indicating ...

Telomir announced results from its recent preclinical studies conducted in human cell lines. These studies demonstrated the ability of ...

First-year student documents emotional 6-hour journey from Polokwane to University of Venda, sharing family moments and campus arrival experiences.

Telomir Pharmaceuticals (TELO) announceS results from recent preclinical studies demonstrating the ability of Telomir-1 to fully reverse oxidative stress in human cell lines.

TELO READ THE FULL TELO RESEARCH REPORT Telomir Pharmaceuticals (NASDAQ:TELO) is a preclinical stage biopharmaceutical company developing a product designed to lengthen the DNA’s protective telomere ...

Detroit police said they are investigating the death of an infant on the city's east side after they received a call of an ...

Senator Telo Taitague said it’s time to prioritize fixing Guam's roads, introducing a bill that would allocate $10 million ...

Sen. Telo T. Taitague introduced Bill 39-38, which seeks to allocate $10 million to the Department of Public Works from ...

Sen. Telo T. Taitague introduced Bill 39-38, a measure aimed at allocating $10 million to the Department of Public Works from ...

After about six months of waiting, lawmakers finally sat down with finance and emergency management officials on Friday to ...

Our Top PicksBest free planOoma TeloBest customer support for VoIP serviceVonageBest desktop-based VoIPGrasshopper Staying ...